Literatura académica sobre el tema "CDC50 proteins"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "CDC50 proteins".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "CDC50 proteins"
Furuta, Nobumichi, Konomi Fujimura-Kamada, Koji Saito, Takaharu Yamamoto y Kazuma Tanaka. "Endocytic Recycling in Yeast Is Regulated by Putative Phospholipid Translocases and the Ypt31p/32p–Rcy1p Pathway". Molecular Biology of the Cell 18, n.º 1 (enero de 2007): 295–312. http://dx.doi.org/10.1091/mbc.e06-05-0461.
Texto completoSaito, Koji, Konomi Fujimura-Kamada, Nobumichi Furuta, Utako Kato, Masato Umeda y Kazuma Tanaka. "Cdc50p, a Protein Required for Polarized Growth, Associates with the Drs2p P-Type ATPase Implicated in Phospholipid Translocation in Saccharomyces cerevisiae". Molecular Biology of the Cell 15, n.º 7 (julio de 2004): 3418–32. http://dx.doi.org/10.1091/mbc.e03-11-0829.
Texto completoGarcía-Sánchez, Sebastián, María P. Sánchez-Cañete, Francisco Gamarro y Santiago Castanys. "Functional role of evolutionarily highly conserved residues, N-glycosylation level and domains of the Leishmania miltefosine transporter-Cdc50 subunit". Biochemical Journal 459, n.º 1 (14 de marzo de 2014): 83–94. http://dx.doi.org/10.1042/bj20131318.
Texto completoLópez-Marqués, Rosa L., Lisbeth R. Poulsen, Susanne Hanisch, Katharina Meffert, Morten J. Buch-Pedersen, Mia K. Jakobsen, Thomas Günther Pomorski y Michael G. Palmgren. "Intracellular Targeting Signals and Lipid Specificity Determinants of the ALA/ALIS P4-ATPase Complex Reside in the Catalytic ALA α-Subunit". Molecular Biology of the Cell 21, n.º 5 (marzo de 2010): 791–801. http://dx.doi.org/10.1091/mbc.e09-08-0656.
Texto completoHanadate, Yuki, Yumiko Saito-Nakano, Kumiko Nakada-Tsukui y Tomoyoshi Nozaki. "Identification and Characterization of the Entamoeba Histolytica Rab8a Binding Protein: A Cdc50 Homolog". International Journal of Molecular Sciences 19, n.º 12 (30 de noviembre de 2018): 3831. http://dx.doi.org/10.3390/ijms19123831.
Texto completoBryde, Susanne, Hanka Hennrich, Patricia M. Verhulst, Philippe F. Devaux, Guillaume Lenoir y Joost C. M. Holthuis. "CDC50 Proteins Are Critical Components of the Human Class-1 P4-ATPase Transport Machinery". Journal of Biological Chemistry 285, n.º 52 (20 de octubre de 2010): 40562–72. http://dx.doi.org/10.1074/jbc.m110.139543.
Texto completovan der Velden, Lieke M., Catharina G. K. Wichers, Adriana E. D. van Breevoort, Jonathan A. Coleman, Robert S. Molday, Ruud Berger, Leo W. J. Klomp y Stan F. J. van de Graaf. "Heteromeric Interactions Required for Abundance and Subcellular Localization of Human CDC50 Proteins and Class 1 P4-ATPases". Journal of Biological Chemistry 285, n.º 51 (14 de octubre de 2010): 40088–96. http://dx.doi.org/10.1074/jbc.m110.139006.
Texto completoMisu, Kenjiro, Konomi Fujimura-Kamada, Takashi Ueda, Akihiko Nakano, Hiroyuki Katoh y Kazuma Tanaka. "Cdc50p, a Conserved Endosomal Membrane Protein, Controls Polarized Growth in Saccharomyces cerevisiae". Molecular Biology of the Cell 14, n.º 2 (febrero de 2003): 730–47. http://dx.doi.org/10.1091/mbc.e02-06-0314.
Texto completoLi, Xin, Baohui Chen, Sawako Yoshina, Tanxi Cai, Fuquan Yang, Shohei Mitani y Xiaochen Wang. "Inactivation of Caenorhabditis elegans aminopeptidase DNPP-1 restores endocytic sorting and recycling in tat-1 mutants". Molecular Biology of the Cell 24, n.º 8 (15 de abril de 2013): 1163–75. http://dx.doi.org/10.1091/mbc.e12-10-0730.
Texto completoPark, Chong J., Sukgil Song, Thomas H. Giddings, Hyeon-Su Ro, Krisada Sakchaisri, Jung-Eun Park, Yeon-Sun Seong, Mark Winey y Kyung S. Lee. "Requirement for Bbp1p in the Proper Mitotic Functions of Cdc5p in Saccharomyces cerevisiae". Molecular Biology of the Cell 15, n.º 4 (abril de 2004): 1711–23. http://dx.doi.org/10.1091/mbc.e03-07-0461.
Texto completoTesis sobre el tema "CDC50 proteins"
Lamy, Anaïs. "Lipid Flippases from Plasmodium Parasites : from Heterologous Production towards Functional Characterization". Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLS447/document.
Texto completoMalaria is a devastating disease caused by a parasite of the genus Plasmodium. Due to the spread of strains resistant to current antimalarial drugs, it is necessary to understand essential physiological functions of the parasite in order to find new drug targets. Membrane transport proteins are an important class of drug targets in humans, as they perform essential physiological roles of the cell. However, for Plasmodium parasites, just a few membrane transporters have been biochemically described. Recent gene-deletion studies in malaria mouse models have shown that the Plasmodium P4-ATPase, or lipid flippase, ATP2 is essential for the parasite. In eukaryotes, the phospholipid translocation activity of P4-ATPases is needed to maintain the asymmetric distribution of membranes, a key element in many essential processes like vesicle budding or apoptosis. Lipid flippases form heteromeric complexes with members of the Cdc50 protein family, also found in the genomes of Plasmodium parasites. To understand the functional role of these still putative transporters during malaria infection we need to study their transport mechanism and identify their substrate(s). We have conducted the heterologous expression in Saccharomyces cerevisiae of ATP2 in complex with the Cdc50 subunits from three different Plasmodium species. We succeeded to co-express the ATP2 ortholog of P. chabaudi (PcATP2) and the related putative PcCdc50 proteins. By co-immunoprecipitation and Fluorescence-detection Size Exclusion Chromatography, we have managed to identify the Cdc50 β-subunit that associates to PcATP2: PcCdc50.1. We then purified the complex PcATP2/PcCdc50.1 using immobilized nanobodies that recognize the GFP fused at the C-terminal end of PcATP2 and we initiated the functional characterization using ATPase and phosphorylation activity assays
Jacquot, Aurore. "Co-expression et caractérisation fonctionnelle d’un transporteur de lipides (une « flippase ») de la levure S. cerevisiae : l’ATPase P4 Drs2p, en complexe avec sa sous-unité associée Cdc50p". Thesis, Paris 11, 2012. http://www.theses.fr/2012PA11T081/document.
Texto completoTrans-Golgi membranes and plasma membranes of eukaryotic cells are asymmetric, with their cytosolic leaflet enriched in aminophospholipids (APLs: phosphatidylserine and phosphatidylethanolamine). Dissipation of this asymmetry is involved in many (patho)physiological processes. P4 ATPases are prime candidates for APL transport and for maintaining asymmetry across membranes. In addition, yeast deleted for P4 ATPases display membrane trafficking defects. Besides, CDC50 proteins have been shown to interact physically with P4 type ATPases, and this interaction is important for addressing the complex to the right destination, and possibly also for its function. To gain insight into the molecular mechanism of lipid transport by P4 ATPases, the goal of my thesis was to develop the co-expression, in yeast, of a functional P4 ATPase, Drs2p, together with its partner, Cdc50p. The strategy we developed allowed us to obtain a membrane fraction enriched in Drs2p (~3%), mainly in complex with Cdc50p. Functional characterization of the complex identified phosphatidylinositol-4-phosphate (PI4P), a major regulator of membrane trafficking, as a crucial component for rapid completion of the Drs2p/Cdc50p catalytic cycle. We also purified the complex in one step on streptavidin beads. Finally, we started investigating the potential auto-inhibitory roles of the C-terminus (as the C-terminus of Drs2p contains a PI4P binding site) and the N-terminus of Drs2p, by expressing various truncated versions of Drs2p. Our work sets the stage for detailed functional and structural characterization of the Drs2p/Cdc50p complex and its role in membrane traffic
Dieudonne, Thibaud. "Functional and Structural Characterization of Lipid Flippases : The Yeast Drs2p/Cdc50p and the Disease-Related Human Atp8b1/Cdc50a Complexes Structure and Autoregulation of a P4-ATPase Lipid Flippase Screening of Detergents for Stabilization of Functional Membrane Proteins High phosphatidylinositol 4-phosphate (PI4P)-dependent ATPase activity for the Drs2p-Cdc50p flippase after removal of its N- and C-terminal extensions Slow Phospholipid Exchange between a Detergent-Solubilized Membrane Protein and Lipid-Detergent Mixed Micelles: Brominated Phospholipids as Tools to Follow Its Kinetics". Thesis, université Paris-Saclay, 2020. http://www.theses.fr/2020UPASS023.
Texto completoLiving cells are surrounded by membranes organized in bilayers, separating the intracellular medium from the extracellular environment. A hallmark of eukaryotic membranes from the late secretory/endocytic pathways is the asymmetric distribution of phospholipids between the two leaflets. Indeed, phosphatidylcholine (PC) and sphingolipids (SL) are mainly found in the outer leaflet whereas phosphatidylserine (PS) and phosphatidylethanolamine (PE) are sequestered in the inner leaflet. This asymmetry is maintained thanks to different membrane lipid transporters. Among them, flippases, which are transporters fueled by ATP hydrolysis, translocate lipids from the outer to the inner leaflet. Flippases belong to the P4-ATPase family and have been linked to several diseases. For instance, mutated forms of a human P4-ATPase, ATP8B1, are responsible for intrahepatic cholestasis, a severe liver disease. In this thesis, we investigated the regulatory mechanism of two flippases, the yeast PS-specific flippase complex Drs2p/Cdc50p, and the human disease-related flippase complex ATP8B1/CDC50A. Both proteins were expressed in S. cerevisiae and purified for downstream functional characterization. Our results demonstrate that both flippases are tightly regulated by phosphoinositides and autoinhibited by their N- and C-terminal extensions
Neutzner, Melanie. "Regulatoren des Zellteilungszyklus der Hefe Saccharomyces cerevisiae : die Polo-Kinase Cdc5 und der Ubiquitinierungsfaktor Hct1 /". [S.l. : s.n.], 2003. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB10605153.
Texto completoBizzari, Farid Fouad Mahmoud. "Cdc55 controls the balance of phosphatases to coordinate spindle assembly and chromosome disjunction during budding yeast meiosis". Thesis, University of Edinburgh, 2012. http://hdl.handle.net/1842/5876.
Texto completoColeman, Jonathan Allan. "P4-ATPase structure-function relationships : mechanism and roles of ATP8A2-CDC50A in aminophospholipid transport, protein trafficking, and visual disorders". Thesis, University of British Columbia, 2013. http://hdl.handle.net/2429/44073.
Texto completoHysenaj, Lisiena. "Alterations of hematopoiesis during brucellosis". Thesis, Aix-Marseille, 2019. http://www.theses.fr/2019AIXM0251.
Texto completoBrucellosis is a disease that is transmitted from animals to humans. It is caused by the pathogenic bacterium Brucella. During my thesis, I showed that Brucella persists in the bone marrow cells of infected animals. These observations are very important because the bone marrow is an organ of the immune system responsible for the generation of the immune cells, as it is the principal niche of hematopoietic stem cells. During my thesis, I showed that Brucella outer membrane 25 (Omp25) is able to bind SLAMF1, a hematopoietic stem cell molecule. This interaction leads to the production of more myeloid cells by the hematopoietic stem cell. Myeloid cells are the favorite niche of Brucella. Thus, this strategy allows the bacteria to invade the host and establish a long lasting chronic infection. SLAMF 1 appears as a new therapeutic target for controlling chronic infectious diseases, which would represent an important advance in the generation of new drugs
Genga, Kelly Roveran. "Estudo da imunoexpressão de proteínas relacionadas ao ponto de checagem mitótico (CDC20 e MAD2) e ao fuso mitótico (Aurora A e Aurora B) em pacientes portadores de síndrome mielodisplásica". reponame:Repositório Institucional da UFC, 2014. http://www.repositorio.ufc.br/handle/riufc/10358.
Texto completoSubmitted by denise santos (denise.santos@ufc.br) on 2014-12-22T13:55:37Z No. of bitstreams: 1 2014_dis_krgenga.pdf: 2677752 bytes, checksum: a4b47020e1d8a4b4789af7e144a1ce58 (MD5)
Approved for entry into archive by denise santos(denise.santos@ufc.br) on 2014-12-22T13:56:41Z (GMT) No. of bitstreams: 1 2014_dis_krgenga.pdf: 2677752 bytes, checksum: a4b47020e1d8a4b4789af7e144a1ce58 (MD5)
Made available in DSpace on 2014-12-22T13:56:41Z (GMT). No. of bitstreams: 1 2014_dis_krgenga.pdf: 2677752 bytes, checksum: a4b47020e1d8a4b4789af7e144a1ce58 (MD5) Previous issue date: 2014
Síndrome mielodisplásica (SMD) representa um grupo de doenças hematopoéticas heterogêneas, que se caracterizam por alterações morfológicas de dispoese, medula óssea hiperproliferativa, citopenias no sangue periférico e risco aumentado de evolução para leucemia mieloide aguda. A patogênese da SMD envolve múltiplas etapas, com destaque para alterações citogenéticas, porém ainda não está claramente definido como a doença progride. Nesse contexto, o estudo da imunoexpressão de proteínas relacionadas ao ponto de checagem mitótico (CDC20 e MAD2) e ao fuso mitótico (AURORA A e AURORA B) mostra-se promissor. Essas proteínas foram associadas à instabilidade cromossômica, aneuploidia e progressão tumoral em tumores sólidos e neoplasias hematológicas, contribuindo para o surgimento de anormalidades citogenéticas. Na literatura, existem poucos artigos publicados avaliando o impacto da expressão dessas proteínas na evolução de pacientes com SMD. O presente estudo, de caráter retrospectivo, teve como objetivo avaliar a imunoexpressão de CDC20, MAD2, AURORA A e AURORA B em pacientes com SMD e investigar sua relação com variáveis clínicas e laboratoriais. O estudo da expressão proteica foi realizado por imunoistoquímica (microscopia óptica), em 40 biópsias de medula óssea de pacientes portadores de SMD e 10 controles (biópsias de medula óssea para estadiamento de linfoma sem infiltração pela doença). A expressão proteica foi interpretada de forma qualitativa (expressão positiva versus negativa) e quantitativa (% de células positivas após análise de 10 campos em aumento de 400x, assim como pela categorização das amostras positivas em grupos de expressão leve - < 10%, moderada – 10 a 49% e alta - ≥ 50%). Identificou-se, de forma significativa, maior expressão das proteínas CDC20, MAD2 e AURORA B nos pacientes portadores de SMD, quando comparados com os controles (p < 0,05). A análise qualitativa mostrou os seguintes resultados (p < 0,05): 1) maior frequência de expressão negativa de MAD2 em pacientes com duas a três citopenias; 2) maior frequência de expressão negativa de CDC20 em pacientes com plaquetopenias mais graves (<50.000/mm3); 3) maior frequência de expressão positiva de AURORA B entre os pacientes que evoluíram para óbito; 4) menor sobrevida global entre os pacientes com expressão positiva de AURORA B; 5) maior frequência de expressão positiva de AURORA A entre os pacientes com dependência transfusional, citogenética aneuploide, cariótipo complexo e/ou anormal. A análise quantitativa (média ± DP, em %) mostrou os seguintes resultados (p < 0,05): 1) maior expressão de MAD2 e CDC20 em pacientes com plaquetopenias mais graves (<50.000/mm3); 2) maior expressão de MAD2 e CDC20 entre os pacientes que evoluíram para óbito; 3) maior expressão de CDC20 entre os pacientes com três displasias e cariótipo complexo; 4) maior expressão de AURORA B nos pacientes com citogenética alterada. A análise quantitativa por grupos revelou (p < 0,05): 1) maior frequência de alta expressão de CDC20 e MAD2 em pacientes com contagens plaquetárias < 50.000/mm3 e entre os pacientes que evoluíram para óbito durante o período do estudo; 2) menor sobrevida global no grupo de pacientes com expressão ≥ 50% de MAD2 e CDC20 e ≥ 10% de AURORA B. em comparação aos pacientes com expressão negativa e/ou expressão positiva < 50% e < 10%, respectivamente. Tais dados sugerem que expressões alteradas dessas proteínas (hipo ou hiperexpresssão) podem estar relacionadas ao processo de tumorigênese e à progressão da SMD, contribuindo, desse modo, para melhor estratificação de risco e abordagem terapêutica.
Azouaoui, Hassina. "Étude structurale et fonctionnelle d’un transporteur de lipides « une flippase » de la levure S. cerevisiae : l’ATPase P4 Drs2p et sa sous unité-associée Cdc50p". Thesis, Université Paris-Saclay (ComUE), 2016. http://www.theses.fr/2016SACLS224/document.
Texto completoMaintenance of phospholipid asymmetry in eukaryotic cell membranes is essential for cellular integrity and function. P4-ATPases, from the P-type ATPases family, are energy-dependent transporters, together with their CDC50 accessory subunits couple ATP hydrolysis to lipid transport from the exoplasmic to cytoplasmic leaflet to maintain membrane asymmetry.Drs2p is one of these P4-ATPases in the yeast Saccharomyces cerevisiae. Drs2p is localised in trans-Golgi (TGN) membranes in association with its binding partner Cdc50p, which contributes to the correct addressing of Drs2p and probably in the catalyzed transport by Drs2p. Drs2p transport principally phosphatidylserine (PS) in TGN membranes. The PS is important for a several signalling pathways, for example, in apoptosis and recruitment of the proteins implied in various essential cellular process, so, it's very important to understand the mechanism that establishes this asymmetry.To gain in comprehension of molecular mechanism of lipid transport, robust protocols for expression and purification are required. In this work, we present a procedure for high-yield co-expression of Drs2p and Cdc50p. The purification of Drs2p and Cdc50p is achieved in a single step by affinity chromatography on streptavidin beads, yielding, 1-2 mg purified Drs2p/Cdc50p per liter of culture. This procedure allows purification of the complex Drs2p/Cdc50p with stoichiometry to 1:1. Our complex is functional, overal ATP hydrolysis by the complex is dependent of PS, favourite substrate of Drs2p. This hydrolyze is critically dependent on the presence of PI4P, a phosphoinositide involved in regulation of membrane trafficking.Like many P-type ATPases auto-regulate their activity, we examined the possibility that P4-ATPases are auto-regulated. In this work, we use directed mutagenesis and limited proteolysis associated with mass spectrometry for identify peptides. We show that limited proteolysis of a purified complex Drs2p/Cdc50p resulted in up to a 30-50 fold increase of it ATPase activity, which however remained dependent on PI4P. Using thrombin as the protease, Cdc50p remained intact and in complex with Drs2p, which was cleaved at two positions, namely after R104 and after R1290. Our results therefore reveal that trimming off appropriate regions of the terminal extensions of Drs2p can increase its ATPase activity in the presence of PI4P by an enormous factor, thereby identifying a role of N and/or C-terminal extensions in auto-inhibition of Drs2p.Our results open perspectives on the structural and the functional characterization of the lipid transport mechanism by the complex Drs2p/Cdc50p. Furthermore, our procedures open up the possibility of studying the molecular bases of the pathologies associated with the mutations of human P4-ATPases
Vendrell, Arasa Alexandre. "SCF cdc4 regulates msn2 and msn4 dependent gene expression to counteract hog1 induced lethality". Doctoral thesis, Universitat Pompeu Fabra, 2009. http://hdl.handle.net/10803/7153.
Texto completoTambé hem observat que la mort cel·lular causada per l'activació sostinguda de Hog1 és deguda a una inducció d'apoptosi. L'apoptosi induïda per Hog1 és inhibida per la mutació al complexe SCFCDC4. Per tant, la via d'extensió de la vida és capaç de prevenir l'apoptosi a través d'un mecanisme desconegut.
Sustained Hog1 activation leads to an inhibition of cell growth. In this work, we have observed that the lethal phenotype caused by sustained Hog1 activation is prevented by SCFCDC4 mutants. The prevention of Hog1-induced cell death by SCFCDC4 mutation depends on the lifespan extension pathway. Upon sustained Hog1 activation, SCFCDC4 mutation increases Msn2 and Msn4 dependent gene expression that leads to a PNC1 overexpression and a Sir2 deacetylase hyperactivation. Then, hyperactivation of Sir2 is able to prevent cell death caused by sustained Hog1 activation.
We have also observed that cell death upon sustained Hog1 activation is due to an induction of apoptosis. The apoptosis induced by Hog1 is decreased by SCFCDC4 mutation. Therefore, lifespan extension pathway is able to prevent apoptosis by an unknown mechanism.
Capítulos de libros sobre el tema "CDC50 proteins"
Montigny, Cédric, Hassina Azouaoui, Aurore Jacquot, Marc le Maire, Christine Jaxel, Philippe Champeil y Guillaume Lenoir. "Overexpression of Membrane Proteins in Saccharomyces cerevisiae for Structural and Functional Studies: A Focus on the Rabbit Ca2+-ATPase Serca1a and on the Yeast Lipid “Flippase” Complex Drs2p/Cdc50p". En Membrane Proteins Production for Structural Analysis, 133–71. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0662-8_6.
Texto completo"SCF (Skp1—CDC53—F-box protein)". En Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 1762. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_15111.
Texto completoActas de conferencias sobre el tema "CDC50 proteins"
Nath, Somsubhra, Taraswi Banerjee, Debrup Sen, Tania Das y Susanta Roychoudhury. "Abstract 3075: A novel transcriptional role of spindle assembly checkpoint protein Cdc20 regulating the expression of mitotic ubiquitin carrier protein UbcH10". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3075.
Texto completoHu, Die, Brigitte L. Thériault, Vida Talebian, Julie Owen, Richard Marcellus y Rima Al-awar. "Abstract 1222: Validating the WD repeat protein CDC40 as a potential therapeutic target for lung cancer". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1222.
Texto completo